Itinai.com biomedical laboratory close up still scene close u fd75bc8f 7c64 495f bcb3 944db9509d75 3
Itinai.com biomedical laboratory close up still scene close u fd75bc8f 7c64 495f bcb3 944db9509d75 3

Efficacy, Safety, Satisfaction, Adherence to Treatment With Nano-Formulated Cysteamine Tranexamic Acid Cream to Treat Melasma

Efficacy, Safety, Satisfaction, Adherence to Treatment With Nano-Formulated Cysteamine Tranexamic Acid Cream to Treat Melasma

Key Findings

An innovative cream combining cysteamine and tranexamic acid (TXA) showed significant improvement in treating subjects with epidermal melasma.

Results

Continuous improvement in melasma was observed, with modified Melasma Area and Severity Index (mMASI) scores improving by 40%, 57%, and 63% at 30, 60, and 90 days, respectively. 91% of participants experienced melasma improvement.

Conclusion

Nano-formulated cysteamine and TXA combination cream demonstrated significant efficacy in decreasing mMASI score while maintaining a strong safety profile and high patient satisfaction.

Practical Solutions and Value

Clinical trials are essential for safe and effective treatments. Our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research, making it easier for clinicians to access valuable knowledge. Additionally, our mobile apps support scheduling, monitoring treatments, and telemedicine, streamlining operations and improving patient care.

AI-Powered Health Tools

Interactive AI Tools to Help You Understand Your Health

Solutions for Smart Healthcare

Clinical Research